
Laura Cullen DNP, RN, FAAN discusses leadership and systems infrastructure ahead of her keynote at the Roswell Park Evidence-Based Practice Symposium.

Laura Cullen DNP, RN, FAAN discusses leadership and systems infrastructure ahead of her keynote at the Roswell Park Evidence-Based Practice Symposium.

Fumiko Chino, MD, discusses strategies for oncology nurses to address unproven treatments like ivermectin while maintaining patient trust.

Oncology dietitian Gabrielle Raucci explores the role of creatine in cancer care, highlighting when to use it and risks during active treatment.

The FDA has approved perioperative pembrolizumab and enfortumab vedotin for adult patients with muscle-invasive bladder cancer.

In the phase 3 RASolute 302 trial, oral KRAS inhibitor daraxonrasib nearly doubled median overall survival to 13.2 months in pancreatic cancer.

Stephanie Desrosiers discusses strategies for oncology nurses to manage chemotherapy shortages, ensuring patient safety, equity, and mental health.

NYU Langone experts discuss multidisciplinary care, diagnostic challenges, and nursing's role in treating rare bone and soft tissue sarcomas.

Drs. Sledge and Pastorini discuss how AI-powered molecular profiling corrected a misdiagnosis and the vital "early warning" role of oncology nurses.

FDA approves gedatolisib for HR+/HER2– breast cancer. Learn about the VIKTORIA-1 trial, dosing, and nursing strategies for managing stomatitis.

FDA approves SC isatuximab-irfc with the CirCLIQ on-body injector, streamlining multiple myeloma care and reducing nursing burden.

Donna Berizzi discusses how LeanTaaS capacity management tools reduce nurse burnout by optimizing outpatient workflows and improving patient access.

Dr. Rodney Haring discusses the 2026 AACR Cancer Disparities Report and the critical role of oncology navigators in tribal and rural health equity.

Oncology nurse Kerry Mann details the protocols and patient-centered strategies for bringing advanced precision medicine to local community clinics.

Maite San Miguel and a new survey highlight how specialized training and clinical autonomy are vital for optimizing multiple myeloma outcomes.

Oncology nurse Diane Stanaway offers essential sun protection strategies as NJ prepares for the heat of the 2026 World Cup and rising skin cancer rates.

Rita M. Jakubowski, NP, explains how multidisciplinary age-friendly assessments and the CHARM study improve outcomes for older transplant patients.

Diane Stanaway, MSN, RN, highlights the importance of long-term skin protection for oncology patients during high-exposure events like the World Cup.

Nicholas Hornstein, MD, PhD discusses ctDNA in colorectal cancer, the INTERCEPT-TT trial, building Northwell's GI oncology program, and what better drugs will look like.

Dr. Sriram Machineni explains why GLP-1 medications help manage cardiovascular health and inflammation in breast cancer survivorship.

Teddi Mellencamp highlights the vital bond and advocacy of oncology nurses during the 2026 Extraordinary Healer awards ceremony in San Antonio.

Christina Klawitter, MSN, RN, OCN, discusses how meticulous pre-planning and team delegation optimize safety and patient care in clinical trials.

Dr. Morvarid Rezaie discusses how oncology nurses can leverage medical cannabis to address polypharmacy and enhance opioid synergy for symptom control.

Dan Silver, PA-C, discusses the importance of early intervention in penile rehabilitation and the APP’s role as a partner in prostate cancer recovery.

MSK researchers report that daraxonrasib, a breakthrough KRAS-targeted drug, nearly doubles survival time and improves quality of life for patients.

Susan Rux, PhD, discusses why new nurses leave oncology and how improved communication and teamwork can stabilize the healthcare workforce.

Dan Silver, PA-C, discusses proactive strategies for managing treatment-related erectile dysfunction and penile rehabilitation in prostate cancer.

Deanna Lewis, PA-C, explores how reframing communication as clinical infrastructure fosters trust, psychological safety, and innovation in oncology.

Kilan C. Ashad-Bishop details how chronic heat impacts oncology treatment adherence, hydration, and financial security for patients.

Explore how ctDNA and AI algorithms are optimizing bladder cancer treatment and managing BCG shortages, as discussed at OneOncology APP Symposium.

Larry Bilbrey of Tennessee Oncology explains how AI scribes reduce documentation burden and burnout while improving patient-provider engagement.